Quia Pharma AB
0
0
+SEK0,00+0% 00:00 Hari ini
Statistik
Tertinggi hari ini
-
Terendah hari ini
-
Tertinggi 52M
-
Terendah 52M
-
Volume
-
Vol. rata2
-
Kap. pasar
0
Rasio P/E
-
Imbal hasil dividen
-
Dividen
-
Pesaing
Daftar ini adalah analisis berdasarkan peristiwa pasar terbaru. Ini bukan rekomendasi investasi.
Tentang
Quia Pharma AB (publ) engages in the research, development, and commercialization of medicines based on Uni-Qleaver, a drug delivery platform. The company develops drugs through its pegylation technology platform. Its product pipeline includes QPG-1030 (pegylated teduglutide) for the treatment of short bowel syndrome, and QPG-1029 under pre-clinical development for stable plasma concentration, as well as antibody-drug conjugates being developed using the company's Uni-Qleaver technology-platform. The company was formerly known as QuiaPEG Pharmaceuticals Holding AB (publ) and changed its name to Quia Pharma AB (publ). Quia Pharma AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
Tampilkan lebih banyak
CEO
Dr. Vidar Wendel-Hansen M.D., Ph.D.
Karyawan
2
Negara
Swedia
ISIN
SE0023849716
Pencatatan
0 Komentar
Bagikan pendapatmu
FAQ
Apa simbol saham Quia Pharma AB?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa Stockholm Exchange, saham Quia Pharma AB diperdagangkan dengan simbol QUIA-BT-UN.ST.
Berapa jumlah karyawan Quia Pharma AB?▼
Per 8 Oktober 2026, perusahaan memiliki 2 karyawan.
Quia Pharma AB berada di sektor apa?▼
Quia Pharma AB beroperasi di sektor Kesehatan & Kebugaran.
Kapan Quia Pharma AB menyelesaikan split saham?▼
Quia Pharma AB belum melakukan split saham baru-baru ini.
Di mana kantor pusat Quia Pharma AB?▼
Kantor pusat Quia Pharma AB berlokasi di Uppsala, Swedia.